Display options
Cite
Vanderhaeghen T, Timmermans S, Watts D, et al. Reprogramming of glucocorticoid receptor function by hypoxia. EMBO Rep. 2021;23(1):e53083doi: 10.15252/embr.202153083.
Vanderhaeghen, T., Timmermans, S., Watts, D., Paakinaho, V., Eggermont, M., Vandewalle, J., Wallaeys, C., Van Wyngene, L., Van Looveren, K., Nuyttens, L., Dewaele, S., Vanden Berghe, J., Lemeire, K., De Backer, J., Dirkx, L., Vanden Berghe, W., Caljon, G., Ghesquière, B., De Bosscher, K., Wielockx, B., Palvimo, J. J., Beyaert, R., & Libert, C. (2022). Reprogramming of glucocorticoid receptor function by hypoxia. EMBO reports, 23(1), e53083. https://doi.org/10.15252/embr.202153083
Vanderhaeghen, Tineke, et al. "Reprogramming of glucocorticoid receptor function by hypoxia." EMBO reports vol. 23,1 (2022): e53083. doi: https://doi.org/10.15252/embr.202153083
Vanderhaeghen T, Timmermans S, Watts D, Paakinaho V, Eggermont M, Vandewalle J, Wallaeys C, Van Wyngene L, Van Looveren K, Nuyttens L, Dewaele S, Vanden Berghe J, Lemeire K, De Backer J, Dirkx L, Vanden Berghe W, Caljon G, Ghesquière B, De Bosscher K, Wielockx B, Palvimo JJ, Beyaert R, Libert C. Reprogramming of glucocorticoid receptor function by hypoxia. EMBO Rep. 2022 Jan 05;23(1):e53083. doi: 10.15252/embr.202153083. Epub 2021 Oct 26. PMID: 34699114.
Copy Download .nbib Format: NLM
Share it on

EMBO Rep. 2022 Jan 05;23(1):e53083. doi: 10.15252/embr.202153083. Epub 2021 Oct 26.

Reprogramming of glucocorticoid receptor function by hypoxia.

EMBO reports

Tineke Vanderhaeghen, Steven Timmermans, Deepika Watts, Ville Paakinaho, Melanie Eggermont, Jolien Vandewalle, Charlotte Wallaeys, Lise Van Wyngene, Kelly Van Looveren, Louise Nuyttens, Sylviane Dewaele, Joke Vanden Berghe, Kelly Lemeire, Joey De Backer, Laura Dirkx, Wim Vanden Berghe, Guy Caljon, Bart Ghesquière, Karolien De Bosscher, Ben Wielockx, Jorma J Palvimo, Rudi Beyaert, Claude Libert

Affiliations

  1. VIB Center for Inflammation Research, Ghent, Belgium.
  2. Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  3. Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.
  4. DFG Research Centre and Cluster of Excellence for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
  5. Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
  6. Department of Biomedical Sciences, University of Antwerp, Universiteitsplein, Wilrijk, Belgium.
  7. Metabolomics Expertise Center, Center for Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
  8. Metabolomics Expertise Center, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
  9. Translational Nuclear Receptor Research Lab, VIB Center for Medical Biotechnology, Ghent, Belgium.
  10. Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

PMID: 34699114 DOI: 10.15252/embr.202153083

Abstract

Here, we investigate the impact of hypoxia on the hepatic response of glucocorticoid receptor (GR) to dexamethasone (DEX) in mice via RNA-sequencing. Hypoxia causes three types of reprogramming of GR: (i) much weaker induction of classical GR-responsive genes by DEX in hypoxia, (ii) a number of genes is induced by DEX specifically in hypoxia, and (iii) hypoxia induces a group of genes via activation of the hypothalamic-pituitary-adrenal (HPA) axis. Transcriptional profiles are reflected by changed GR DNA-binding as measured by ChIP sequencing. The HPA axis is induced by hypothalamic HIF1α and HIF2α activation and leads to GR-dependent lipolysis and ketogenesis. Acute inflammation, induced by lipopolysaccharide, is prevented by DEX in normoxia but not during hypoxia, and this is attributed to HPA axis activation by hypoxia. We unfold new physiological pathways that have consequences for patients suffering from GC resistance.

© 2021 The Authors.

Keywords: crosstalk; hypoxia; inflammation; mechanism; metabolism

References

  1. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. J Am Med Assoc 288: 862-871 - PubMed
  2. Basnyat B, Starling JM (2015) Infectious diseases at high altitude. Microbiol Spectr 3: 1-7 - PubMed
  3. Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W (2002a) Glucocorticoids as prophylaxis against acute mountain sickness. Clin Endocrinol 57: 761-767 - PubMed
  4. Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W (2002b) Hypothalamic-pituitary-adrenal axis following glucocorticoid prophylaxis against acute mountain sickness. Horm Metab Res 34: 318-324 - PubMed
  5. Batie M, del Peso L, Rocha S (2018) Hypoxia and chromatin: a focus on transcriptional repression mechanisms. Biomedicines 6: 1-19 - PubMed
  6. Bauer A, Tronche F, Wessely O, Kellendonk C, Reichardt HM, Steinlein P, Schütz G, Beug H (1999) The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 13: 2996-3002 - PubMed
  7. Beishuizen A, Thijs LG (2003) Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res 9: 3-24 - PubMed
  8. Belanger AJ, Luo Z, Vincent KA, Akita GY, Cheng SH, Gregory RJ, Jiang C (2007) Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor α/retinoid X receptor. Biochem Biophys Res Commun 364: 567-572 - PubMed
  9. Bellingham DL, Sar M, Cidlowski JA (1992) Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol Endocrinol 6: 2090-2102 - PubMed
  10. Berger MM, Macholz F, Sareban M, Schmidt P, Fried S, Dankl D, Niebauer J, Bärtsch P, Mairbäurl H (2017) Inhaled budesonide does not prevent acute mountain sickness after rapid ascent to 4559 m. Eur Respir J 50: 1-4 - PubMed
  11. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ (2007) Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109: 4313-4319 - PubMed
  12. Bleymehl K, Pérez-Gómez A, Omura M, Moreno-Pérez A, Macías D, Bai Z, Johnson RS, Leinders-Zufall T, Zufall F, Mombaerts P (2016) A sensor for low environmental oxygen in the mouse main olfactory epithelium. Neuron 92: 1196-1203 - PubMed
  13. Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30: 2114-2120 - PubMed
  14. Bolsoni-Lopes A, Alonso-Vale MIC (2015) Lipolysis and lipases in white adipose tissue - An update. Arch Endocrinol Metab 59: 335-342 - PubMed
  15. Bougarne N, Paumelle R, Caron S, Hennuyer N, Mansouri R, Gervois P, Staels B, Haegeman G, De Bosscher K (2009) PPARα blocks glucocorticoid receptor α-mediated transactivation but cooperates with the activated glucocorticoid receptor α for transrepression on NF-κB. Proc Natl Acad Sci USA 106: 7397-7402 - PubMed
  16. Bruder ED, Taylor JK, Kamer KJ, Raff H (2008) Development of the ACTH and corticosterone response to acute hypoxia in the neonatal rat. Am J Physiol Regul Integr Comp Physiol 295: 1195-1203 - PubMed
  17. Calo E, Wysocka J (2013) Modification of enhancer chromatin: what, how, and why? Mol Cell 49: 825-837 - PubMed
  18. Chang AJ, Ortega FE, Riegler J, Madison DV, Krasnow MA (2015) Oxygen regulation of breathing through an olfactory receptor activated by lactate. Nature 527: 240-244 - PubMed
  19. Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma’ayan A (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14: 1-14 - PubMed
  20. Chen H-Y, Lin Y-M, Chung H-C, Lang Y-D, Lin C-J, Huang J, Wang W-C, Lin F-M, Chen Z, Huang H-D et al (2012) MiR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 72: 3631-3641 - PubMed
  21. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang G, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH (2000) Hypoxia inducible factor-a binding and ubiquitylation by the von hippel-lindau tumor suppressor protein *. J Biol Chem 275: 25733-25741 - PubMed
  22. Cummins EP, Keogh CE, Crean D, Taylor CT (2016) The role of HIF in immunity and inflammation. Mol Aspects Med 47-48: 24-34 - PubMed
  23. Cuzzocrea S, Bruscoli S, Mazzon E, Crisafulli C, Donato V, Di Paola R, Velardi E, Esposito E, Nocentini G, Riccardi C (2008) Peroxisome proliferator-activated receptor-α contributes to the anti-inflammatory activity of glucocorticoids. Mol Pharmacol 73: 323-337 - PubMed
  24. Dallman MF, Akana SF, Jacobson L, Levin N, Cascio CS, Shinsako J (1987) Characterization of corticosterone feedback regulation of ACTH secretion. Ann N Y Acad Sci 512: 402-414 - PubMed
  25. Dallman MF, Akana SF, Levin N, Walker CD, Bradbury MJ, Suemaru S, Scribner KS (1994) Corticosteroids and the control of function in, the hypothalamo-pituitary-adrenal (HPA) axis. Ann N Y Acad Sci 746: 22-31 - PubMed
  26. Daniel Bird A, McDougall ARA, Seow B, Hooper SB, Cole TJ (2015) Minireview: glucocorticoid regulation of lung development: lessons learned from conditional GR knockout mice. Mol Endocrinol 29: 158-171 - PubMed
  27. De Bosscher K, Beck IM, Ratman D, Vanden BW, Libert C (2016) Activation of the glucocorticoid receptor in acute inflammation: the SEDIGRAM concept. Trends Pharmacol Sci 37: 4-16 - PubMed
  28. De Bosscher K, Vanden Berghe W, Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24: 488-522 - PubMed
  29. Dejager L, Pinheiro I, Puimège L, Fan YD, Gremeaux L, Vankelecom H, Libert C (2010) Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice. J Biol Chem 285: 31073-31086 - PubMed
  30. Dendoncker K, Timmermans S, Vandewalle J, Eggermont M, Lempiäinen J, Van Hamme E, Dewaele S, Vandevyver S, Ballegeer M, Souffriau J et al (2019) TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile. Proc Natl Acad Sci USA 116: 12942-12951 - PubMed
  31. Dong Y, Poellinger L, Gustafsson JÅ, Okret S (1988) Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 2: 1256-1264 - PubMed
  32. Escoter-Torres L, Greulich F, Quagliarini F, Wierer M, Uhlenhaut NH (2020) Anti-inflammatory functions of the glucocorticoid receptor require DNA binding. Nucleic Acids Res 48: 8393-8407 - PubMed
  33. Franke K, Gassmann M, Wielockx B (2013) Erythrocytosis: the HIF pathway in control. Blood 122: 1122-1128 - PubMed
  34. Garcia-alvarez M, Marik P, Bellomo R (2014) Sepsis-associated hyperlactatemia. Crit Care 18: 1-11 - PubMed
  35. Gonzales GF, Tapia V (2013) Association of high altitude-induced hypoxemia to lipid profile and glycemia in men and women living at 4100m in the Peruvian Central Andes. Endocrinol Y Nutr 60: 79-86 - PubMed
  36. Grabacka M, Pierzchalska M, Dean M, Reiss K (2016) Regulation of ketone body metabolism and the role of PPARα. Int J Mol Sci 17: 2093 - PubMed
  37. de Guia RM, Herzig S (2015) How do glucocorticoids regulate lipid metabolism? Adv Exp Med Biol 872: 127-144 - PubMed
  38. Guo B, Huang X, Cooper S, Broxmeyer HE (2017) Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment. Nat Med 23: 424-428 - PubMed
  39. Harrell CS, Rowson SA, Neigh GN (2015) Pharmacological stimulation of hypoxia inducible factor-1α facilitates the corticosterone response to a mild acute stressor. Neurosci Lett 600: 75-79 - PubMed
  40. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK (2010) Simple Combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589 - PubMed
  41. Jenniskens M, Weckx R, Dufour T, Vander PS, Pauwels L, Derde S, Téblick A, Güiza F, Van Den Berghe G, Langouche L (2018) The hepatic glucocorticoid receptor is crucial for cortisol homeostasis and sepsis survival in humans and male mice. Endocrinology 159: 2790-2802 - PubMed
  42. Jungermann K, Kietzmann T (2000) Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31: 255-260 - PubMed
  43. Kanczkowski W, Sue M, Bornstein SR (2016) Adrenal gland microenvironment and its involvement in the regulation of stress-induced hormone secretion during sepsis. Front Endocrinol 7: 1-9 - PubMed
  44. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103: 1489-1498 - PubMed
  45. Kiers D, Wielockx B, Peters E, van Eijk LT, Gerretsen J, John A, Janssen E, Groeneveld R, Peters M, Damen L et al (2018) Short-term hypoxia dampens inflammation in vivo via enhanced adenosine release and adenosine 2B receptor stimulation. EBioMedicine 33: 144-156 - PubMed
  46. Kim D, Paggi JM, Park C, Bennett C, Salzberg SL (2019) Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 37: 907-915 - PubMed
  47. Kim S, Foong D, Cooper MS, Seibel MJ, Zhou H (2018) Comparison of blood sampling methods for plasma corticosterone measurements in mice associated with minimal stress-related artefacts. Steroids 135: 69-72 - PubMed
  48. Kitsteiner JM, Whitworth JD, Nashelsky J (2011) Preventing acute mountain sickness. Am Fam Physician 84: 398-400 - PubMed
  49. Kleiman A, Hubner S, Rodriguez Parkitna JM, Neumann A, Hofer S, Weigand MA, Bauer M, Schmid W, Schutz G, Libert C et al (2012) Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J 26: 722-729 - PubMed
  50. Kodama T, Shimizu N, Yoshikawa N, Makino Y, Ouchida R, Okamoto K, Hisada T, Nakamura H, Morimoto C, Tanaka H (2003) Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression *. J Biol Chem 278: 33384-33391 - PubMed
  51. Kuo T, McQueen A, Chen T-C, Wang J-C (2015) Regulation of glucose homeostasis by glucocorticoids. Adv Exp Med Biol 872: 99-126 - PubMed
  52. Lee SST, Gonzalez FJ (1996) Targeted disruption of the peroxisome proliferator-activated receptor alpha gene, PPARalpha. Ann N Y Acad Sci 804: 524-529 - PubMed
  53. Leonard MO, Godson C, Brady HR, Taylor CT (2005) Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J Immunol 174: 2250-2257 - PubMed
  54. Leone TC, Weinheimer CJ, Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96: 7473-7478 - PubMed
  55. Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, Semenza GL, Polotsky VY (2006) Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1α. Physiol Genomics 25: 450-457 - PubMed
  56. Liao Y, Smyth GK, Shi W (2014) FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30: 923-930 - PubMed
  57. Libert C, Brouckaert P, Shaw A, Fiers W (1990) Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice. Eur J Immunol 20: 691-694 - PubMed
  58. Libert C, Van BS, Brouckaert P, Shaw A, Fiers W, Libert C, Bladel VAN, Brouckaert P, Shaw A (1991) Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. This information is current as Why The JI ? Submit online. • Rapid Reviews ! 30 days * from submission to initial decision • No. J Immunol 146: 2625-2632 - PubMed
  59. Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15: 1-21 - PubMed
  60. Marchi D, Santhakumar K, Markham E, Li N, Storbeck KH, Krone N, Cunliffe VT, Van Eeden FJM (2020) Bidirectional crosstalk between hypoxia-inducible factor and glucocorticoid signalling in zebrafish larvae. PLoS Genet 16: 1-28 - PubMed
  61. McGarry JD, Foster DW (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49: 395-420 - PubMed
  62. McKeown SR (2014) Defining normoxia, physoxia and hypoxia in tumours - Implications for treatment response. Br J Radiol 87: 1-12 - PubMed
  63. Minneci PC, Deans KJ, Eichacker PQ, Natanson C (2009) The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect 15: 308-318 - PubMed
  64. Mylonis I, Simos G, Paraskeva E (2019) Hypoxia-inducible factors and the regulation of lipid metabolism. Cells 8: 1-16 - PubMed
  65. Nakayama K, Kataoka N (2019) Regulation of gene expression under hypoxic conditions. Int J Mol Sci 20: 1-15 - PubMed
  66. Nishiyama Y, Goda N, Kanai M, Niwa D, Osanai K, Yamamoto YU, Senoo-Matsuda N, Johnson RS, Miura S, Kabe Y et al (2012) HIF-1α induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice. J Hepatol 56: 441-447 - PubMed
  67. Park JY, Hwang TK, Park HK, Ahn RS (2014) Differences in cardiovascular and hypothalamic-pituitary-adrenal axis functions between high-altitude visitors and natives during a trek on the Annapurna circuit. Neuroendocrinology 99: 130-138 - PubMed
  68. Pavek P (2016) Pregnane X receptor (PXR)-mediated gene repression and cross-talk of PXR with other nuclear receptors via coactivator interactions. Front Pharmacol 7: 1-16 - PubMed
  69. Raff H, Jacobson L, Cullinan WE (2007) Augmented hypothalamic corticotrophin-releasing hormone mRNA and corticosterone responses to stress in adult rats exposed to perinatal hypoxia. J Neuroendocr 19: 907-912 - PubMed
  70. Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q, Haase VH (2009) Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 29: 4527-4538 - PubMed
  71. Ratman D, Mylka V, Bougarne N, Pawlak M, Caron S, Hennuyer N, Paumelle R, De Cauwer L, Thommis J, Rider MH et al (2016) Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα. Nucleic Acids Res 44: 10539-10553 - PubMed
  72. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P et al (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541 - PubMed
  73. Rock PB, Johnson TS, Larsen RF, Fulco CS, Trad LA, Cymerman A (1989) Dexamethasone as prophylaxis for acute mountain sickness. Chest 95: 568-573 - PubMed
  74. Rose AJ, Herzig S (2013) Metabolic control through glucocorticoid hormones: an update. Mol Cell Endocrinol 380: 65-78 - PubMed
  75. Rose AJ, Vegiopoulos A, Herzig S (2010) Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J Steroid Biochem Mol Biol 122: 10-20 - PubMed
  76. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354 - PubMed
  77. Semenza GL (2011) Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol 76: 347-353 - PubMed
  78. Sevilla LM, Pérez P (2018) Glucocorticoid receptor signaling in skin barrier function. Intech 13: 23-44 - PubMed
  79. Spiga F, Walker JJ, Terry JR, Lightman SL (2014) HPA axis-rhythms. Compr Physiol 4: 1273-1298 - PubMed
  80. Steidl C, Leimeister C, Klamt B, Maier M, Nanda I, Dixon M, Clarke R, Schmid M, Gessler M (2000) Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family. Genomics 66: 195-203 - PubMed
  81. Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB et al (2020) Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. J Am Med Assoc 324: 1330-1341 - PubMed
  82. Taylor A (2011) High-altitude illnesses: physiology, risk factors, prevention, and treatment. Rambam Maimonides Med J 2: 1-18 - PubMed
  83. Timmermans S, Souffriau J, Libert C (2019) A general introduction to glucocorticoid biology. Front Immunol 10: 1-17 - PubMed
  84. Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, Liddle C, Schwalie P, Hübner N, Evans RM (2013) Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 49: 158-171 - PubMed
  85. Van Bogaert T, Vandevyver S, Dejager L, Van Hauwermeiren F, Pinheiro I, Petta I, Engblom D, Kleyman A, Schütz G, Tuckermann J et al (2011) Tumor necrosis factor inhibits glucocorticoid receptor function in mice: a strong signal toward lethal shock. J Biol Chem 286: 26555-26567 - PubMed
  86. Van Looveren K, Timmermans S, Vanderhaeghen T, Wallaeys C, Ballegeer M, Souffriau J, Eggermont M, Vandewalle J, Van WL, De BK et al (2020) Glucocorticoids limit lipopolysaccharide-induced lethal inflammation by a double control system. EMBO Rep 32: 1-17 - PubMed
  87. Van Wyngene L, Vandewalle J, Libert C (2018) Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med 10: e8712 - PubMed
  88. Vanderhaeghen T, Beyaert R, Libert C (2021) Bidirectional crosstalk between hypoxia inducible factors and glucocorticoid signalling in health and disease. Front Immunol 12: 1-19 - PubMed
  89. Vandewalle J, Libert C (2020) Glucocorticoids in sepsis: to be or not to be. Front Immunol 11: 1-14 - PubMed
  90. Vandewalle J, Luypaert A, De BK, Libert C (2018) Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab 29: 42-54 - PubMed
  91. Vandewalle J, Timmermans S, Paakinaho V, Vancraeynest L, Dewyse L, Vanderhaeghen T, Wallaeys C, Van Wyngene L, Van Looveren K, Nuyttens L et al (2021) Combined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis. Cell Metab 33: 1-14 - PubMed
  92. Vegiopoulos A, Herzig S (2007) Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 275: 43-61 - PubMed
  93. Vettori A, Greenald D, Wilson GK, Peron M, Facchinello N, Markham E, Sinnakaruppan M, Matthews LC, McKeating JA, Argenton F et al (2017) Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization. Proc Natl Acad Sci USA 114: 9948-9953 - PubMed
  94. Wagner AE, Huck G, Stiehl DP, Jelkmann W, Hellwig-Bürgel T (2008) Dexamethasone impairs hypoxia-inducible factor-1 function. Biochem Biophys Res Commun 372: 336-340 - PubMed
  95. Wang JC, Gray NE, Kuo T, Harris CA (2012) Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci 2: 1-9 - PubMed
  96. Wang XL, Suzuki R, Lee K, Tran T, Gunton JE, Saha AK, Patti M-E, Goldfine A, Ruderman NB, Gonzalez FJ et al (2009) Ablation of ARNT/HIF1β in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones. Cell Metab 9: 428-439 - PubMed
  97. Wang Y, Ma Y-Y, Song X-L, Cai H-Y, Chen J-C, Song L-N, Yang R, Lu J (2012) Upregulations of glucocorticoid-induced leucine zipper by hypoxia and glucocorticoid inhibit proinflammatory cytokines under hypoxic conditions in macrophages. J Immunol 188: 222-229 - PubMed
  98. Wang Y, Nakajima T, Gonzalez FJ, Tanaka N (2020) PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. Int J Mol Sci 21: 2061 - PubMed
  99. Wielockx B, Meneses A (2016) PHD2: from hypoxia regulation to disease progression. Hypoxia 4: 53-67 - PubMed
  100. Yang N, Berry A, Sauer C, Baxter M, Donaldson IJ, Forbes K, Donn R, Matthews L, Ray D (2020) Hypoxia regulates GR function through multiple mechanisms involving microRNAs 103 and 107. Mol Cell Endocrinol 518: 111007 - PubMed
  101. Yasuhara M, Ohama T, Matsuki N, Saito H, Shiga J, Inoue K, Kurokawa K, Teramoto T (1991) Induction of fatty liver by fasting in suncus. J Lipid Res 32: 887-891 - PubMed
  102. Zhang C, Qiang Q, Jiang Y, Hu L, Ding X, Lu Y, Hu G (2015) Effects of hypoxia inducible factor-1α on apoptotic inhibition and glucocorticoid receptor downregulation by dexamethasone in AtT-20 cells. BMC Endocr Disord 15: 1-9 - PubMed
  103. Zheng C-R, Chen G-Z, Yu J, Qin J, Song P, Bian S-Z, Xu B-D, Tang X-G, Huang Y-T, Liang X et al (2014) Inhaled budesonide and oral dexamethasone prevent acute mountain sickness. Am J Med 127: 1001-1009.e2 - PubMed
  104. Zhu X, Liu Y, Li N, He Q (2020) Inhaled budesonide for the prevention of acute mountain sickness: a meta-analysis of randomized controlled trials. Am J Emerg Med 38: 1627-1634 - PubMed

Publication Types

Grant support